168 related articles for article (PubMed ID: 1793043)
1. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.
Ooi CE; Weiss J; Elsbach P
Agents Actions; 1991 Sep; 34(1-2):274-7. PubMed ID: 1793043
[TBL] [Abstract][Full Text] [Related]
2. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.
Ooi CE; Weiss J; Elsbach P; Frangione B; Mannion B
J Biol Chem; 1987 Nov; 262(31):14891-4. PubMed ID: 3667613
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
Ooi CE; Weiss J; Doerfler ME; Elsbach P
J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
[TBL] [Abstract][Full Text] [Related]
4. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
5. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
Elsbach P; Weiss J
Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
Elsbach P
Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
[TBL] [Abstract][Full Text] [Related]
7. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
8. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
9. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
[TBL] [Abstract][Full Text] [Related]
10. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
[TBL] [Abstract][Full Text] [Related]
13. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
Mannion BA; Kalatzis ES; Weiss J; Elsbach P
J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411
[TBL] [Abstract][Full Text] [Related]
14. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
Capodici C; Weiss J
J Immunol; 1996 Jun; 156(12):4789-96. PubMed ID: 8648126
[TBL] [Abstract][Full Text] [Related]
15. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.
Iovine NM; Elsbach P; Weiss J
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10973-8. PubMed ID: 9380744
[TBL] [Abstract][Full Text] [Related]
16. Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins.
Ooi CE; Weiss J; Levy O; Elsbach P
J Biol Chem; 1990 Sep; 265(26):15956-62. PubMed ID: 2203792
[TBL] [Abstract][Full Text] [Related]
17. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
[TBL] [Abstract][Full Text] [Related]
18. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
Gazzano-Santoro H; Parent JB; Grinna L; Horwitz A; Parsons T; Theofan G; Elsbach P; Weiss J; Conlon PJ
Infect Immun; 1992 Nov; 60(11):4754-61. PubMed ID: 1398985
[TBL] [Abstract][Full Text] [Related]
19. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow.
Lennartsson A; Pieters K; Vidovic K; Gullberg U
J Leukoc Biol; 2005 Mar; 77(3):369-77. PubMed ID: 15590754
[TBL] [Abstract][Full Text] [Related]
20. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
